In non-small cell lung cancer, SUVmax was correlated with CD8(+) TILs as well as CD163(+) tumor-associated macrophages, FoxP3(+) Treg cells, and PD-1(+) and PD-L1(+) cells24. This evidence concerns the gene CD8A and neoplasm.